Skip to main content

Table 3 Characteristics of the retroperitoneal fibrosis patients with malignancies (n = 38)

From: Association of retroperitoneal fibrosis with malignancy and its outcomes

Case

Sex

Age at RPF diagnosis

Age at malignancy diagnosis

Malignancy site

Malignancy type

Stage (TNM)

1

M

68

68

Lung

Adenocarcinoma

I

2

M

76

76

Lung

NSCLC

IV

3

M

52

52

Stomach

Adenocarcinoma

IV

4

M

67

67

Stomach

Adenocarcinoma

IV

5

F

82

82

Stomach

Adenocarcinoma

6

M

68

67

Small intestine

GIST

IV

7

M

49

49

Colon

Adenocarcinoma

IIA

8

M

52

51

Colon

Adenocarcinoma

IIIB,

9

M

54

54

Pancreas

Adenocarcinoma

10

M

78

78

Pancreas

Adenocarcinoma

11

M

47

46

Kidney

Clear cell

II

12

M

64

64

Kidney

Clear cell

I

13

M

51

51

Renal pelvis

TCC

IV

14*

F

79

79

Renal pelvis

TCC

III

15

F

77

78

Renal pelvis

TCC

IV

16

F

75

75

GB

Adenocarcinoma

17

M

67

67

Bladder

TCC

I

18†

F

67

67

Bone

Adenocarcinoma

IV

19

M

74

74

Prostate

Adenocarcinoma

II

20

M

73

73

Peritoneum

MM

III

21

F

64

64

Peritoneum

NHL

III

22

F

75

75

Lymph node

Squamous

IV

23

F

50

49

Thyroid

PTC

I

24‡

M

67

69

Lung

Adenocarcinoma

I

25

M

53

51

Stomach

Signet ring

I

26

M

68

67

Colon

Adenocarcinoma

IIIB

27§

M

78

80

Rectum

Adenocarcinoma

28

M

40

43

Peritoneum

Liposarcoma

IIIB

29

F

42

39

Cervix uteri

Adeno

II

30

M

49

52

BM

MDS

31‡

M

67

71

BM

MM

32†

F

67

62

Breast

Adenocarcinoma

II

33

F

66

72

Thyroid

PTC

II

34¶

M

71

63

Larynx

Squamous

IV

35¶

M

71

60

Lung

Squamous

I

36

M

65

82

Stomach

Adenocarcinoma

I

37§

M

78

71

Stomach

Adenocarcinoma

I

38

F

64

45

Skin

Basal cell

I

  1. RPF retroperitoneal fibrosis; NSCLC non-small cell lung cancer; GIST gastrointestinal stromal tumor; TCC transitional cell carcinoma; GB gall bladder; BM bone marrow; NHL non-Hodgkin lymphoma; PTC papillary thyroid cancer; MDS myelodysplastic syndrome; MM multiple myeloma. *,†RPF newly developed while the cancer worsened and spread. †,‡,§,¶Those cases were the same patient. RPF and cancer were diagnosed within a 1-year interval in 22 cases (case numbers 1–22) and a greater than 5-year interval in 7 cases (case numbers 32–38)